Skip to main content
· 10/17/2001

Lena Gallagher, on Behalf of a Class v. Abbott Laboratories and Miles D. White

Citations

  • 269 F.3d 806
  • 2001 U.S. App. LEXIS 22409

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that the failure to disclose a compliance letter from the FDA did not render the CEO’s projection of continued growth false or misleading absent evidence that the CEO did not honestly believe in the projection
  • explaining that the Form 10-K provides “snapshots” of a registrant’s overall financial position
  • explaining that securities laws do not require continuous disclosure
  • describing the rule’s application to “registration statements and annual 10-K reports”
  • “[F]irms are entitled to keep silent (about good news as well as bad news) unless positive law creates a duty to disclose.”
  • \[F]irms are entitled to keep silent (about good news as well as bad news) unless positive law creates a duty to disclose.\

Source: CourtListener parenthetical corpus (CC0).

Judges: Posner, Easterbrook, Kanne

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.